Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;24(12):1761-1770.
doi: 10.1038/ejhg.2016.80. Epub 2016 Jun 29.

Loss of function of the retinoid-related nuclear receptor (RORB) gene and epilepsy

Affiliations

Loss of function of the retinoid-related nuclear receptor (RORB) gene and epilepsy

Gabrielle Rudolf et al. Eur J Hum Genet. 2016 Dec.

Abstract

Genetic generalized epilepsy (GGE), formerly known as idiopathic generalized epilepsy, is the most common form of epilepsy and is thought to have predominant genetic etiology. GGE are clinically characterized by absence, myoclonic, or generalized tonic-clonic seizures with electroencephalographic pattern of bilateral, synchronous, and symmetrical spike-and-wave discharges. Despite their strong heritability, the genetic basis of generalized epilepsies remains largely elusive. Nevertheless, recent advances in genetic technology have led to the identification of numerous genes and genomic defects in various types of epilepsies in the past few years. In the present study, we performed whole-exome sequencing in a family with GGE consistent with the diagnosis of eyelid myoclonia with absences. We found a nonsense variant (c.196C>T/p.(Arg66*)) in RORB, which encodes the beta retinoid-related orphan nuclear receptor (RORβ), in four affected family members. In addition, two de novo variants (c.218T>C/p.(Leu73Pro); c.1249_1251delACG/p.(Thr417del)) were identified in sporadic patients by trio-based exome sequencing. We also found two de novo deletions in patients with behavioral and cognitive impairment and epilepsy: a 52-kb microdeletion involving exons 5-10 of RORB and a larger 9q21-microdeletion. Furthermore, we identified a patient with intellectual disability and a balanced translocation where one breakpoint truncates RORB and refined the phenotype of a recently reported patient with RORB deletion. Our data support the role of RORB gene variants/CNVs in neurodevelopmental disorders including epilepsy, and especially in generalized epilepsies with predominant absence seizures.

PubMed Disclaimer

Conflict of interest statement

Dr N Tommerup receives funding from the University of Copenhagen (UCPH), Lundbeck Foundation, and The Danish Council for Independent Research – Medical Sciences. Dr KL Helbig, Dr S Tang, Dr DN Shinde, Dr R Huether, and Dr HM Lu are employed by and receives a salary from Ambry Genetics. Exome sequencing is among its commercially available tests. Dr S Coulbaut and Dr M Abbas are UCB Pharma employees. Dr Scheffer reports grants from NHMRC and NIH during the conduct of the study: Annals of Neurology, Epileptic Disorders, and Neurology; personal fees from UCB, Athena Diagnostics, Transgenomics, and GlaxoSmithKline, outside the submitted work; in addition, Dr Scheffer has a patent A Diagnostic Method for Epilepsy with royalties paid. Hannah Stamberger is PhD fellow of the Fund for Scientific Research Flanders. Dr Heather Mefford receives funding from the National Institutes of Health. Dr Ingo Helbig is supported by intramural funds of the University of Kiel, by a grant from the German Research Foundation (HE5415/3-1) within the EuroEPINOMICS framework of the European Science Foundation and grants of the German Research Foundation (DFG, HE5415/5-1, HE 5415/6-1), German Ministry for Education and Research (01DH12033, MAR 10/012), and German chapter of the International League against Epilepsy (DGfE). He is also supported by the Children's Hospital of Philadelphia (CHOP) with the Genomics Research Initiative Network (GRIN). Dr Szepetowski reports grants from French National Research Agency (ANR), UCB-Pharma France, and European Union FP7 during the conduct of the study. All the other authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Inherited nonsense RORB variant segregating in a family with GGE with eyelid myoclonia (family 1). (a) Pedigree with GGE. DNA numbers are indicated under each corresponding family member. Empty symbols represent unaffected individuals. ILS, intermittent light stimulation; PPR, photoparoxysmal response. Patients 19–25 have been phenotyped and collected after the initial report on the family. Note that the variant was not found in neither individual 1 nor 2, which – together with the genetic exclusion of non-paternity (data not shown) – suggest germline mosaicism. (b) DNA sequence traces (both strands) corresponding to the heterozygous c.196C>T variant (arrow) in exon 3 of the RORB gene (patient no. 4, top) and to a wild-type unaffected individual (family member no. 16, bottom). (c) Predicted mutant p.Arg66* RORβ protein. The different domains of the wild-type RORβ protein (Genbank NP_008845) (top) and the corresponding truncated mutant protein (bottom) are schematically represented. Numbers at the top of each protein indicate amino-acid positions from the N-terminus (left) to the C-terminus (right). DBD, DNA-binding domain; LBD, ligand-binding domain; AF2, activation function domain. (d) cDNA sequence traces showing the presence of the heterozygous c.196C>T variant (arrow) in RORB transcripts extracted from lymphoblastoid cell lines of patients 4 (top) and 13 (bottom) and of control individual no. 16 (middle). No difference was observed upon treatment with puromycin (data not shown).
Figure 2
Figure 2
The de novo 9q21 microdeletions found in epileptic patients converge on RORB. (a) aCGH profile of the 8.5-Mb microdeletion event (from 70 984 481 to 79 549 501 nt, hg19 coordinates) detected in patient 9A1117. (b) aCGH profile of the 52-kb de novo partial microdeletion event (from 77 261 322 to 77 313 598 nt, hg19 coordinates) detected in patient GE0705. (c) Map of all microdeletions comprising RORB reported to date in epileptic patients. Note the existence of two de novo truncating events on either 5′ and 3′ sides of RORB, in addition to the partial microdeletion of exons 5–10 reported here (patient GE0705).
Figure 3
Figure 3
Conventional (RHG) karyotype and fluorescent in situ hybridization (FISH) showing the complex chromosomal rearrangement in patient 9A1117. (Top) Conventional karyotype. (a) Small supernumerary ring chromosome (arrow) (b) Derivative chromosome 9 from a t(9;21) translocation replacing a normal chromosome 21 (arrow). (Bottom) FISH analysis. (ce) FISH with RP11-404E6 (9q21.3) probe in TRITC (red) and 9pter probe (Cytocell) in FITC (green) showing the normal chromosome 9 (chr9), the 9q13q21.13 deletion (del9q) lacking the RP11-404E6 signal. Note that RP11-404E6 probe cross-hybridizes on chromosome 14. Additional rearrangements included (d) isochromosome 9p i(9p) showing two 9pter green signals and (e) a derivative 9 chromosome from a t(9;21) translocation der(9) showing a single 9pter green signal. (f) FISH with centromeric chromosome 9 probe in Texas Red and 9pter probe in FITC (green) (Cytocell) showing the supernumerary small ring chromosome 9r(9) with a centromeric red signal but no telomeric signal. A full color version of this figure is available at the European Journal of Human Genetics journal online.
Figure 4
Figure 4
Mapping of seq[GRch37]t(9;19)(q21;q12)dn breakpoint in case DK8393. (a) Mate-pair mapping place the chromosome 9 breakpoint (vertical arrow) within the first intron of RORB, between two oppositely oriented clusters of 19 mate-pair reads (b). (c) Sanger sequencing with forward (F) and reverse primer (R) pairs reveal two small duplications (blue bases in italics) associated with the chromosome 9 breakpoint at nt 77174984 (arrow). The black bars illustrate the BLAT results of the forward and reverse sequences in the UCSC Genome Browser. The amino acids (AA) encoded by the first three exons are shown on the top. If the gene could be transcribed despite the loss of the highly conserved and complex promoter (unlikely, see Supplementary Figure S3), the use of the next start codon (green arrow) distal to the translocation breakpoint (in exon 3) will result in the deletion of the first 74 AA of RORB (blue box). A full color version of this figure is available at the European Journal of Human Genetics journal online.

References

    1. Nabbout R, Scheffer IE: Genetics of idiopathic epilepsies. Handb Clin Neurol 2013; 111: 567–578. - PubMed
    1. Helbig I, Lowenstein DH: Genetics of the epilepsies: where are we and where are we going? Curr Opin Neurol 2013; 26: 179–185. - PMC - PubMed
    1. Dibbens LM, Heron SE, Mulley JC: A polygenic heterogeneity model for common epilepsies with complex genetics. Genes Brain Behav 2007; 6: 593–597. - PubMed
    1. Scheffer IE, Mefford HC: Epilepsy: beyond the single nucleotide variant in epilepsy genetics. Nat Rev Neurol 2014; 10: 490–491. - PubMed
    1. Rubboli G, Gardella E, Capovilla G: Idiopathic generalized epilepsy (IGE) syndromes in development: IGE with absences of early childhood, IGE with phantom absences, and perioral myoclonia with absences. Epilepsia 2009; 50 (Suppl 5): 24–28. - PubMed

Publication types

Substances